Rotavirus vaccines

Vaccines

Volumn , Issue , 2008, Pages 715-734

  Clark, H Fred ^a,b   Offit, Paul A ^a,c   Parashar, Umesh D ^d   Ward, Richard L ^e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85112123246     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3611-1.50032-5     Document Type: Chapter

References (281)

1. I de Zoysa and RG Feachem (1985) Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization. Bull World Health Organ 63 569-583.
2. AZ Kapikian, Y Hoshino and RM Chanock (2001) Rotaviruses. BN Fields, DM Knipe, PM Howley (Eds) Fields Virology 4th ed Philadelphia: Lippincott-Raven 1787-1833. 2
3. CD Brandt, HW Kim, JO Rodriguez, et al. (1983) Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol 18 71-78.
4. RI Glass, PE Kilgore, RC Holman, et al. (1996) The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis 174(Suppl 1), S5-S11.
5. PE Kilgore, RC Holman, MJ Clarke and RI Glass (1995) Trends of diarrheal disease-associated mortality in U.S. children, 1968 through 1991. JAMA 274 1143-1148.
6. UD Parashar, RC Holman, MJ Clarke, et al. (1998) Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis 177 13-17.
7. AW Tucker, AC Haddix, JS Bresee, et al. (1998) Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 279 1371-1376.
8. S Huilan, LG Zhen, MM Mathan, et al. (1991) Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull World Health Organ 69 549-555.
9. MM Levine, G Losonsky, D Herrington, et al. (1986) Pediatric diarrhea: the challenge of prevention. Pediatr Infect Dis 5(Suppl), S29-S43.
10. SM Cook, RI Glass, CW LeBaron and M-S Ho (1990) Global seasonality of rotavirus infections. Bull World Health Organ 68 171-177.
11. C Bern, J Martines, I de Zoysa and RI Glass (1992) The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ 70 705-714.
12. J Bryce, C Boschi-Pinto, K Shibuya and RE Black WHO Child Health Epidemiology Reference Group (2005) WHO estimates of the causes of death in children. Lancet 365 1114-1116.
13. UD Parashar, EG Hummelman, JS Bresee, et al. (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9 565-572.
14. UD Parashar, CJ Gibson, JS Bresee and RI Glass (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12 304-306.
15. Oral Rehydration Therapy (1983) An Annotated Bibliography (Scientific Publication No 445) Washington, DC: Pan-American Health Organization
16. S Tallett, C MacKenzie, P Middleton, et al. (1977) Clinical, laboratory and epidemiologic features of a viral gastroenteritis in infants and children. Pediatrics 60 217-222.
17. M Carr, D McKendrick and T Spyridakis (1978) The clinical features of infantile gastroenteritis due to rotavirus. Scand J Infect Dis 8 241-243.
18. A Kovacs, L Chan, C Hotrakitya, et al. (1987) Rotavirus gastroenteritis: clinical and laboratory features and use of the Rotazyme test. Am J Dis Child 141 161-166.
19. W Rodriguez, H Kim, J Arrobio, et al. (1977) Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J Pediatr 91 188-193.
20. M Estes (2001) Rotaviruses and their replication. BN Fields, DM Knipe, PM Howley (Eds) Fields Virology 4th ed Philadelphia: Lippincott-Raven 747-1786.
21. K Sato, Y Inaba, T Shinozaki, et al. (1981) Isolation of human rotavirus in cell cultures. Arch Virol 69 155-160.
22. T Urasawa, S Urasawa and K Taniguchi (1981) Sequential passages of human rotavirus in MA-104 cells. Microbiol Immunol 25 1025-1035.
23. CA Mebus, M Kono, NR Underdahl and MJ Twiehaus (1971) Cell culture propagation of neonatal calf diarrhea (scours) virus. Can Vet J 12 69-72.
24. HH Malherbe and M Strickland-Cholmley (1969) Simian virus SA11 and the related O agent. Arch Ges Virusforsch 22 235-245.
25. K Midthun, HB Greenberg, Y Hoshino, et al. (1985) Reassortant rotaviruses as potential live rotavirus vaccine candidates. J Virol 53 949-954.
26. HF Clark, PA Offit, KT Dolan, et al. (1986) Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotaviruses. Vaccine 4 25-31.
27. K Midthun, Y Hoshino, AZ Kapikian and RM Chanock (1986) Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. J Clin Microbiol 24 822-826.
28. Y Hoshino, MM Sereno, K Midthun, et al. (1985) Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A 82 8701-8704.
29. PA Offit and G Blavat (1986) Identification of the two rotavirus genes determining neutralization specificities. J Virol 57 376-378.
30. PA Offit, HF Clark, G Blavat and HB Greenberg (1986) Reassortant rotaviruses containing structural proteins VP3 and VP7 from different parents induce antibodies protective against each parental serotype. J Virol 60 491-496.
31. M Sabara, JE Gilchrist, GR Hudson and LA Babiuk (1985) Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol 53 58-66.
32. AR Kalica, HB Greenberg, RG Wyatt, et al. (1981) Genes of human (strain WA) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology 112 385-390.
33. JM Ball, P Tian, CQY Zeng, et al. (1996) Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272 101-104.
34. G Larralde, B Li, AZ Kapikian and M Gorziglia (1991) Serotype-specific epitopes present on the VP 8 subunit of rotavirus VP 4 protein. J Virol 65 3213-3218.
35. MKY Gorziglia, K Green, K Nishikawa, et al. (1988) Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol 62 2979-2984.
36. Y Hoshino, RG Wyatt and HB Greenberg (1984) Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque reduction neutralization. J Infect Dis 149 694-702.
37. L Svensson, H Sheshbaradaran, T Visikari, et al. (1987) Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1). J Gen Virol 68 1993-1999.
38. RL Ward, DR Knowlton, GM Schiff, et al. (1989) Relative concentrations of serum neutralizing antibody to VP 3 and VP 7 proteins in adults infected with a human rotavirus. J Virol 62 1543-1549.
39. RL Ward, DR Knowlton, HG Greenberg, et al. (1990) Serum-neutralizing antibody to VP 4 and VP 7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol 64 2687-2691.
40. S Matsui, E Mackow and H Greenberg (1989) Molecular determinants of rotavirus neutralization and protection. Adv Virus Res 36 181-214.
41. PR Dormitzer, YD Yoder, SD Trask, et al. (July 15–19, 2006) ASV abstract W51–3, Madison, WI. Amer Soc Virol Abstracts
42. MK Estes and J Cohen (1989) Rotavirus gene structure and function. Microbiol Rev 53 410-449.
43. CA Mebus, EL Stair, NR Underdahl and MJ Twiehaus (1974) Pathology of neonatal calf diarrhea induced by a reo-like virus. Vet Pathol 8 490-505.
44. GR Pearson and MS McNulty (1977) Pathological changes in the small intestine of neonatal pigs infected with a pig reovirus-like agent (rotavirus). J Comp Pathol 87 363-375.
45. DR Snodgrass, A Ferguson, F Allan, et al. (1979) Small intestinal morphology and epithelial cell kinetics in lamb rotavirus infections. Gastroenterology 76 477-481.
46. WG Starkey, J Collins, TS Wallis, et al. (1986) Kinetics, tissue specificity and pathological changes in murine rotavirus infection of mice. J Gen Virol 67 2625-2634.
47. IH Holmes, BJ Ruck, RF Bishop and GP Davidson (1975) Infantile enteritis viruses: morphogenesis and morphology. J Virol 16 937-943.
48. H Suzuki and T Konno (1975) Reovirus-like particles in jejunal mucosa of a Japanese infant with acute infectious non-bacterial gastroenteritis. Tohoku J Exp Med 115 199-211.
49. A Torres-Medina (1984) Effect of rotavirus and/or Escherichia coli infection on the aggregated lymphoid follicles in the small intestine of neonatal gnotobiotic calves. Am J Vet Res 45 652-660.
50. I Uhnoo, M Riepenhoff-Talty, T Dharakul, et al. (1990) Extramucosal spread and development of hepatitis with rhesus rotavirus in immunodeficient and normal mice. J Virol 64 361-368.
51. M Riepenhoff-Talty, K Schaekel, H Clark, et al. (1993) Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res 33 394-399.
52. GP Davidson, DG Gall, M Petric, et al. (1977) Human rotavirus enteritis induced in conventional piglets: intestinal structure and transport. J Clin Invest 60 1402-1409.
53. DY Graham, JW Sackman and MK Estes (1984) Pathogenesis of rotavirus-induced diarrhea: preliminary studies in miniature swine piglet. Dig Dis Sci 29 1028-1035.
54. Y Hoshino, MM Sereno, AZ Kapikian, et al. (1993) Genetic determinants of rotavirus virulence studied in gnotobiotic piglets. Vaccines 93 Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 277-282.
55. RL Ward, BB Mason, DI Bernstein, et al. (1997) Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene. J Virol 71 6267-6270.
56. AZ Kapikian, H Wha, RG Wyatt, et al. (1976) Human reovirus-like agent as the major pathogen associated with ‘winter’ gastroenteritis in hospitalized infants and young children. N Engl J Med 294 965-972.
57. I Perez-Schael, G Daoud, L White, et al. (1984) Rotavirus shedding by newborn children. J Med Virol 14 127-136.
58. IL Chrystie, BM Totterdell and JE Banatvala (1978) Asymptomatic endemic rotavirus infections in the newborn. Lancet 1 1176-1178.
59. WM Wenman, D Hinde, S Feltham and M Gurwith (1979) Rotavirus infection in adults: results of a prospective family study. N Engl J Med 301 303-306.
60. FR Velazquez, DO Matson, JJ Calva, et al. (1996) Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335 1022-1028.
61. DO Matson, R Velazquez, AL Morrow, et al. (1995) Protective effect of breastfeeding upon first rotavirus infection and illness in a cohort of Mexican children. Pediatr Res 37 128.
62. M Riepenhoff-Talty, PC Lee, PJ Carmody, et al. (1982) Age-dependent rotavirus-enterocyte interactions. Proc Soc Exp Biol Med 170 146-154.
63. N Fukuhara, O Yoshie, S Kitaoka and T Konno (1988) Role of VP 3 in human rotavirus internalization after target cell attachment via VP 7. J Virol 62 2209-2218.
64. KT Kaljot, RD Shaw, DH Rubin and HB Greenberg (1988) Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol 62 1136-1144.
65. MK Estes, DY Graham and BB Mason (1981) Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol 39 879-888.
66. E Lebenthal and PC Lee (1980) Development of functional response in human exocrine pancreas. Pediatrics 66 556-560.
67. REM Black, MH Merson, ASSM Rahman, et al. (1980) A two-year study of bacterial, viral and parasitic agents associated with diarrhea in rural Bangladesh. J Infect Dis 142 660-664.
68. RL Noble, RW Sidwell, AW Mahoney, et al. (1983) Influence of malnutrition and alterations in dietary protein on murine rotavirus disease. Proc Soc Exp Biol Med 173 417-426.
69. JD Morrey, RW Sidwell, RL Noble, et al. (1984) Effects of folic acid malnutrition on rotaviral infection in mice. Proc Soc Exp Biol Med 176 77-83.
70. PM Newsome and KA Coney (1985) Synergistic rotavirus and Escherichia coli diarrheal infection of mice. Infect Immun 47 573-574.
71. S Tzipori, T Makin, M Smith and F Krautil (1982) Enteritis in foals induced by rotavirus and enterotoxigenic Escherichia coli. Aust Vet J 58 20-23.
72. R Bishop, G Barnes, E Cipriani and J Lund (1983) Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med 309 72-76.
73. DI Bernstein, DS Sander, VE Smith, et al. (1991) Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis 164 277-283.
74. RL Ward and D Bernstein (1994) Protection against rotavirus disease after natural infection. J Infect Dis 169 900-904.
75. TK Fisher, P Valentiner-Branth, H Steinsland, et al. (2002) Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, West Africa. J Infect Dis 186 593-597.
76. DO Matson, ML O'Ryan, I Herrera, et al. (1993) Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J Infect Dis 167 577-583.
77. B Coulson, K Grimwood, I Hudson, et al. (1992) Role of coproantibody in clinical protection of children during reinfection with rotavirus. J Clin Microbiol 30 1678-1684.
78. ML O'Ryan, DO Matson, MK Estes and LK Pickering (1994) Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infection. J Infect Dis 169 504-511.
79. R Yolken, R Wyatt and G Zissis (1978) Epidemiology of human rotavirus types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med 299 1156-1161.
80. R Black, H Greenberg, A Kapikian, et al. (1982) Acquisition of serum antibody to Norwalk virus and rotavirus in relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis 145 483-489.
81. R Bishop, G Barnes, E Cipriani and J Lund (1983) Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med 309 72-76.
82. L Mata, A Simhon, J Urratia, et al. (1983) Epidemiology of rotaviruses in a cohort of 45 Guatemalan Mayan Indian children observed from birth to the age of three years. J Infect Dis 148 452-461.
83. S Chiba, S Nakata, T Urasawa, et al. (1986) Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1 417-421.
84. A Linhares, Y Gabbay, J Mascarenhas, et al. (1988) Epidemiology of rotavirus subgroups and serotypes in Belem, Brazil: a three-year study. Ann Inst Pasteur (Virol) 139 89-99.
85. M Georges-Courbot, J Monges, A Beraud-Cassel, et al. (1988) Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa. Ann Inst Pasteur (Virol) 139 421-428.
86. M Friedman, A Gaul, B Sarov, et al. (1988) Two sequential outbreaks of rotavirus gastroenteritis: evidence for symptomatic and asymptomatic reinfection. J Infect Dis 158 814-822.
87. S Grinstein, J Gomez, J Bercovich and E Biscorn (1989) Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children. Am J Epidemiol 130 300-308.
88. R Reves, M Hossain, K Midthun, et al. (1989) An observational study of naturally acquired immunity in a cohort of 363 Egyptian children. Am J Epidemiol 130 981-988.
89. M O'Ryan, D Matson, M Estes, et al. (1990) Molecular epidemiology of rotavirus in young children attending day care centers in Houston. J Infect Dis 162 810-816.
90. C DeChamps, H Laveran, J Peigue-Lafeville, et al. (1991) Sequential rotavirus infections: characterization of serotypes and electropherotypes. Res Virol 142 39-45.
91. CA Moser, SE Coffin, S Cookinham and PA Offit (1998) Relative importance of rotavirus-specific effector and memory B cell responses in protection against challenge. J Virol 72 1108-1114.
92. H Madore, C Christy, M Pichichero, et al. (1992) Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. J Infect Dis 166 235-243.
93. D Bernstein, R Glass, G Rodgers, et al. (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children. JAMA 273 1191-1196.
94. R Ward and D Bernstein (1995) Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. Vaccine 13 1226-1252.
95. PA Offit and KI Dudzik (1989) Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol 63 3507-3512.
96. PA Offit and KI Dudzik (1990) Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J Virol 64 6325-6328.
97. T Dharakul, L Rott and HB Greenberg (1990) Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8 + T lymphocytes. J Virol 64 4375-4382.
98. M Franco, C Tin and H Greenberg (1997) CD8 + T cells can mediate complete short-term and partial long-term protection against reinfection by rotavirus. J Virol 71 4165-4170.
99. N Kushnir, NA Bos, AW Zuercher, et al. (2001) B2 but not B1 B cells can contribute to CD4 + T cell-mediated clearance of rotavirus in SCID mice. J Virol 75 5482-5490.
100. MM McNeal, JL VanCott, AH Choi, et al. (2002) CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT (R192G). J Virol 76 560-568.
101. DM Bass (1997) Interferon gamma and interleukin 1, but not interferon alpha, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113 81-89.
102. HF Clark, FE Borian, LM Bell, et al. (1988) Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 158 570-587.
103. S Chiba, S Nakata, T Urasawa, et al. (1986) Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 1 417-421.
104. J Burns, M Siadet-Pajouh, A Krishnaney and HB Greenberg (1996) Novel anti-viral effect against murine rotavirus by an anti-VP6 IgA monoclonal antibody that lacks conventional in vitro neutralizing activity. Science 272 104-107.
105. PA Offit and KI Dudzik (1988) Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes. J Virol 62 127-131.
106. D Matson, M O'Ryan, L Pickering, et al. (1992) Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol 30 1056-1061.
107. B Zheng, S Han, Y Yan, et al. (1988) Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus. J Clin Microbiol 26 1506-1512.
108. F Puerto, L Padilla-Noriega, A Zamora-Chavez, et al. (1987) Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. J Clin Microbiol 25 960-963.
109. G Gerna, A Sarasini, M Torsellini, et al. (1990) Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype. J Infect Dis 161 1105-1111.
110. H Clark, K Dolan, P Horton-Slight, et al. (1985) Diverse serologic response to rotavirus infection of infants in a single epidemic. Pediatr Infect Dis 4 626-631.
111. CD Brandt, HW Kim, WJ Rodriguez, et al. (1981) Comparison of direct electron microscopy, immune electron microscopy and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol 13 976-981.
112. AS Rubenstein and MF Miller (1982) Comparison of enzyme immunoassay with electron microscopy procedures for detecting rotavirus. J Clin Microbiol 15 938-944.
113. IL Chrystie, BM Totterdell and JE Banatvala (1983) False positive Rotazyme tests on faecal samples from babies [letter]. Lancet 2 1028.
114. GV Doern, JE Herrman, P Henderson, et al. (1986) Detection of rotavirus with a new polyclonal antibody enzyme immunoassay (Rotazyme II) and commercial latex agglutination test (Rotalex): comparison with a monoclonal antibody enzyme immunoassay. J Clin Microbiol 23 226-229.
115. RC Sanders, AD Campbell and AF Jenkins (1986) Routine detection of human rotavirus by latex agglutination: comparison with latex agglutination, electron microscopy and polyacrylamide gel electrophoresis. J Virol Methods 13 285-290.
116. DJ DiStefano, N Kraiouchkine, L Mallette, et al. (2005) Novel Rotavirus VP7 Typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including subgroup analysis. JCM 43(12), 1-5.
117. K Taniguchi, F Wakasugi, Y Pongsuwanna, et al. (1992) Identification of human and bovine rotavirus serotypes by polymerase chain reaction. Epidemiol Infect 109 303-312.
118. BS Coulson, JR Gentsch, BK Das, et al. (1999) Comparison of enzyme immunoassay and reverse transcriptase PCR for identification of serotype G9 rotaviruses. J Clin Microbiology 37(10), 3187–3193.
119. DJ DiStefano, N Kraiouchkine, L Mallette, et al. (2005) Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J Clin Microbiology 43(12), 1–5.
120. MK Bhan, JF Lew, S Sazawal, et al. (1993) Protection conferred by neonatal rotavirus infection against subsequent diarrhea. J Infect Dis 168 282-287.
121. Institute of Medicine (1986) The prospects of immunizing against rotavirus. New Vaccine Development: Diseases of Importance in Developing Countries Washington, DC: National Academy Press D13-1-D13-12. 2
122. VM Nguyen, VT Nguyen, PL Huynh, et al. (2001) The epidemiology and disease burden of rotavirus in Vietnam: sentinel surveillance at 6 hospitals. J Infect Dis 183 1707-1712.
123. LM Kraft (1957) Studies on the etiology and transmission of epidemic diarrhea of infant mice. J Exp Med 106 743-755.
124. AA Alfieri, JPG Leite, O Nakagomi, et al. (1996) Characterization of human rotavirus genotype P[8]G5 from Brazil by probe-hybridization and sequence. Arch Virol 141 2353-2364.
125. J Gentsch, BK Das, B Jiang, et al. (1993) Similarity of the VP4 protein of human rotavirus strain 116E to that of the bovine B223 strain. Virology 194 424-430.
126. T Nakagomi and O Nakagomi (1989) RNA-RNA hybridization identifies a human rotavirus that is genetically related to feline rotavirus. J Virol 63 1431-1434.
127. D Hrdy (1987) Epidemiology of rotaviral infection in adults. Rev Infect Dis 9 461-469.
128. AV Bartlett, RR Reves and LK Pickering (1988) Rotavirus in infant-toddler day care centers: epidemiology relevant to disease control strategies. J Pediatr 113 435-441.
129. LK Pickering, AV Bartlett, RR Reves and A Morrow (1988) Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J Pediatr 112 361-365.
130. LK Pickering, DG Evans and HL DuPont (1981) Diarrhea caused by Shigella, rotavirus and Giardia in day care centers: prospective study. J Pediatr 99 51-56.
131. HL DuPont and CD Ericsson (1993) Prevention and treatment of traveler's diarrhea. N Engl J Med 328 1821-1827.
132. AL Cunningham, GS Grohmann, J Harkness, et al. (1988) Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus. J Infect Dis 158 386-391.
133. F Hindley, M McIntyre, B Clark, et al. (1987) Heterogeneity of genome rearrangements in rotaviruses isolated from a chronically infected immunodeficient child. J Virol 61 3365-3372.
134. FT Saulsbury, JA Winkelstein and RH Yolken (1980) Chronic rotavirus infection in immunodeficiency. J Pediatr 97 61-65.
135. RJ Yolken, CA Bishop and R Towsend (1982) Infectious gastroenteritis in bone marrow transplant recipients. N Engl J Med 306 1009-1012.
136. NA Cunliffe, JS Gondwe, CD Kirkwood, et al. (2001) Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet 358 550-555.
137. MB Liste, I Natera, JA Suarez, et al. (2000) Enteric Virus Infections and Diarrhea in Healthy and Human Immunodeficiency Virus-Infected Children. Journal of Clinical Microbiology 38(8), 2873-2877.
138. H Oshitani, FC Kasolo, M Mpabalwani, et al. (1994) Association of rotavirus and human immunodeficiency virus infection in children hospitalized with acute diarrhea, Lusaka, Zambia. JID 169 897-900.
139. JP Cegielski, AE Msengi and SE Miller (1994) Enteric viruses associated with HIV infection in Tanzanian children with chronic diarrhea. Pediatric AIDS and HIV infection: Fetus to Adolescent 5 296-299.
140. KL Kotloff, JP Johnson, P Nair, et al. (1994) Diarrheal morbidity during the first 2 years of life among HIV-infected infants. JAMA 271 448-452.
141. AT Pavia, EG Long, RW Ryder, et al. (1992) Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic and epidemiologic features. Ped Infect Dis J 11 996-1003.
142. WJ Moss, J Clements and NA Halsey (2003) Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 81 61-70.
143. JR Gentsch, PA Woods, M Ramachandran, et al. (1996) Review of G and P typing results from a global collection of strains: implications for vaccine development. J Infect Dis 174(Suppl 1), S30-S36.
144. DD Griffin, M Fletcher, ME Levy, et al. (2002) Outbreaks of adult gastroenteritis traced to a single rotavirus genotype. J Infect Dis 185 1502-1505.
145. Y Hoshino and AZ Kapikian (1994) Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children. Trends Microbiol 2 242-249.
146. M Gurwith, W Wenman, D Gurwith, et al. (1983) Diarrhea among infants and young children in Canada: a longitudinal study in three northern communities. J Infect Dis 147 685-692.
147. JS Koopman, VJ Turkish, AS Monto, et al. (1984) Patterns and etiology of diarrhea in three clinical settings. Am J Epidemiol 119 114-123.
148. WJ Rodriguez, HW Kim, CD Brandt, et al. (1987) Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr Infect Dis J 6 170-176.
149. M-S Ho, RI Glass, PF Pinsky and LJ Anderson (1988) Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis 158 1112-1116.
150. M-S Ho, RI Glass, PF Pinsky, et al. (1988) Diarrheal deaths in American children: are they preventable? JAMA 260 3281-3285.
151. D Ing, RI Glass, CW LeBaron and JF Lew (1992) Laboratory-based surveillance for rotavirus in the United States, January 1989–May 1991. MMWR CDC Surveill Summ 41 47-56.
152. CW LeBaron, J Lew, RI Glass, et al. (1990) for the Rotavirus Study Group Annual rotavirus epidemic patterns in North America: results of a five-year retrospective survey of 88 centers in Canada, Mexico and the United States. JAMA 264 983-988.
153. TJ Torok, MJ Clarke, RC Holman and RI Glass (1997) Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991–1996. Pediatr Infect Dis J 16 941-946.
154. DO Matson and MK Estes (1990) Impact of rotavirus infection at a large pediatric hospital. J Infect Dis 162 598-604.
155. MJ Ryan, M Ramsay, D Brown, et al. (1996) Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis 174(Suppl 1), S12-S18.
156. MJ Ferson (1996) Hospitalizations for rotavirus gastroenteritis among children under five years of age in New South Wales. Med J Aust 164 273-276.
157. M Lynch, F O'Halloran, D Whyte, et al. (2001) Rotavirus in Ireland: national estimates of diseases burden, 1997 to 1998. Pediatr Infect Dis J 20 693-698.
158. I Perez-Schael (1996) The impact of rotavirus disease in Venezuela. J Infect Dis 174(Suppl 1), S19-S21.
159. MA Staat, PH Azimi, T Berke, et al. (2002) Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 21 221-227.
160. A Guarino, S Russo, A Castaldo, et al. (1996) Passive immunotherapy for rotavirus-induced diarrhoea in children with HIV infection. AIDS 10 1176-1177.
161. A Guarino, R Canani, S Russo, et al. (1994) Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics 93 12-16.
162. A Guarino, S Guandalini, F Albano, et al. (1991) Enteral immunoglobulins for treatment of protracted rotaviral diarrhea. Pediatr Infect Dis J 10 612-614.
163. R Turner and D Kelsey (1993) Passive immunization for prevention of rotavirus illness in healthy infants. Pediatr Infect Dis J 12 718-722.
164. A Delem, M Lobmann and N Zygraich (1984) A bovine rotavirus developed as a candidate vaccine for use in humans. J Biol Stand 12 443-445.
165. T Vesikari, E Isolauri, A Delem, et al. (1983) Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 2 807-811.
166. CA Mebus, RG White, EP Bass and MJ Twiehaus (1973) Immunity to neonatal calf diarrhea virus. J Am Vet Med Assoc 163 880-883.
167. T Vesikari, E Isolauri, A Delem, et al. (1985) Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 107 189-194.
168. T Vesikari, E Isolauri, E D'Hondt, et al. (1984) Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1 977-980.
169. P De Mol, G Zissis, JP Butzler, et al. (1986) Failure of live, attenuated rotavirus vaccine [letter]. Lancet 2 108.
170. P Hanlon, K Hanlon, V Marsh, et al. (1987) Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1 1342-1345.
171. M Santosham, GW Letson, M Wolff, et al. (1991) A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 163 483-487.
172. Y Maldonado, L Hestvik, M Wilson, et al. (1986) Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants. J Pediatr 109 931-935.
173. CF Lanata, RE Black, R deAguila, et al. (1989) Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 159 452-459.
174. T Vesikari, T Ruuska, A Delem, et al. (1991) Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhea. Acta Paediatr Scand 80 173-180.
175. T Vesikari, E Isolauri, E D'Hondt, et al. (1984) Increased ‘take’ rate of oral rotavirus vaccine in infants after milk feeding [letter]. Lancet 2 700.
176. T Vesikari, T Ruuska, H Bogaerts, et al. (1985) Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. Pediatr Infect Dis J 4 622-625.
177. I Vodopija, Z Baklaic, R Vlatkovic, et al. (1986) Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237. Vaccine 4 233-236.
178. HF Clark, T Furukawa, LM Bell, et al. (1986) Immune response of infants and children to low-passage bovine rotavirus (strain WC3). Am J Dis Child 140 350-356.
179. A Garbag-Chenon, J-L Fontaine, G Lasfargues, et al. (1989) Reactogenicity and immunogenicity of rotavirus WC3 vaccine in 5–12-month-old infants. Res Virol 140 207-217.
180. DI Bernstein, VE Smith, DS Sander, et al. (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 162 1055-1062.
181. RL Ward, DS Sander, GM Schiff and DI Bernstein (1990) Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis 162 1298-1303.
182. MC Georges-Courbot, J Monges, MR Siopathis, et al. (1991) Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142 405-411.
183. AZ Kapikian, K Midthun, Y Hoshino, et al. (1985) Rhesus rotavirus: a candidate vaccine for prevention of human rotavirus disease. RA Lerner, RM Chanock, F Brown (Eds) Molecular and Chemical Basis of Resistance to Parasitic, Bacterial and Viral Diseases Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 357-367.
184. G Stuker, LS Oshiro and NH Schmidt (1980) Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol 11 202-203.
185. K Nishikawa, Y Hoshino, K Taniguchi, et al. (1989) Rotavirus v.p. 7 neutralization epitopes of serotype 3 strains. Virology 171 503-515.
186. GA Losonsky, MB Rennels, AZ Kapikian, et al. (1986) Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU18006) in infants. Pediatr Infect Dis 5 25-29.
187. T Vesikari, AZ Kapikian, A Delem and G Zissis (1986) A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 153 832-839.
188. I Perez-Schael, M Gonzalez, N Daoud, et al. (1987) Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. J Infect Dis 155 334-338.
189. ME Pichichero, GA Losonsky, MB Rennels, et al. (1990) Effect of dose and comparison of measures of vaccine taken for oral rhesus rotavirus vaccine. Pediatr Infect Dis J 9 339-344.
190. ME Pichichero (1990) Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis. J Infect Dis 162 753-755.
191. J Flores, D Daud, N Daud, et al. (1988) Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMV-18006) in newborn infants in Venezuela. Pediatr Infect Dis J 6 260-264.
192. F Jalil, S Zaman, B Carlsson, et al. (1991) Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine. Trans R Soc Trop Med Hyg 85 292-296.
193. T Vesikari, T Rautanen, T Varis, et al. (1990) Rhesus rotavirus candidate vaccine: clinical trial in children vaccinated between 2 and 5 months of age. Am J Dis Child 144 285-289.
194. L Gothefors, G Wadell, P Juto, et al. (1989) Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis 159 753-757.
195. M Santosham, GW Letson, M Wolff, et al. (1991) A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 163 483-487.
196. C Christy, HP Madore, ME Pichichero, et al. (1988) Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J 7 645-650.
197. MB Rennels, GA Losonsky, AE Young, et al. (1990) An efficacy trial of the rhesus rotavirus vaccine in Maryland. Am J Dis Child 144 601-604.
198. J Flores, I Perez-Schael, M Gonzalez, et al. (1987) Protection against severe rotavirus diarrhea by rhesus rotavirus vaccine in Venezuelan children. Lancet 1 882-884.
199. I Perez-Schael, D Garcia, M Gonzalez, et al. (1990) A prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 30 219-229.
200. Global Alliance for Vaccines and Immunization (2001) Rotavirus vaccine development and introduction in developing countries: preparing a global agenda Geneva: World Health Organization 14-15.
201. B Burke and U Desselberger (1996) Rotavirus pathogenicity. Virology 218 299-305.
202. AZ Kapikian, Y Hoshino, RM Chanock and I Perez-Schael (1996) Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 174(Suppl 1), S65-S72.
203. DI Bernstein, RI Glass, G Rodgers, et al. (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children. JAMA 273 1191-1196.
204. MB Rennels, RI Glass, PH Dennehy, et al. (1996) Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: report of the national multicenter trial. Pediatrics 97 7-13.
205. CF Lanata, K Midthun, RE Black, et al. (1996) Safety, immunogenicity and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 174 268-275.
206. AC Linhares, YB Gabbay, JDP Mascarenhas, et al. (1996) Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull World Health Organ 74 491-500.
207. I Perez-Schael, MJ Guntinas, M Perez, et al. (1997) Efficacy of the rhesus-rotavirus based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 337 1181-1187.
208. Centers for Disease Control and Prevention (1999) Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children: recommendations of the Advisory Committee on Immunization Practices. MMWR 48 1-23.
209. M Santosham, LH Moulton, R Reid, et al. (1997) Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr 131 632-638.
210. J Joensuu, E Koskenniemi, XL Pang, et al. (1997) Randomized placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 350 1205-1209.
211. M Staat, N Roberts, D Bernstein, et al. (2002) Effectiveness of RotaShield in preventing severe rotavirus (RV) disease requiring hospitalization. Pediatric Res 51 278A.
212. J Joensuu, E Koskenniemi and T Vesikari (1998) Clinical symptoms associated with rhesus-human reassortant rotavirus vaccine in Finland. Pediatr Infect Dis J 17 334-340.
213. L Gothefors, G Wadell, P Juto, et al. (1989) Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis 159 753-757.
214. JS Breese, SE Arifeen, T Azim, et al. (2001) Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh. Pediatr Infect Dis J 20 1136-1143.
215. Committee on Infectious Diseases, American Academy of Pediatrics (1998) Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 102 1483-1491.
216. Centers for Disease Control and Prevention (1999) Intussusception among recipients of rotavirus vaccine—United States, 1998–1999. MMWR 48 577-581.
217. Committee on Infectious Diseases, American Academy of Pediatrics (1999) Possible association of intussusception with rotavirus vaccination. Pediatrics 104 575.
218. TV Murphy, PM Garguillo, MS Massoudi, et al. (2001) Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344 564-572.
219. P Kramarz, EK France, F Destefano, et al. (2001) Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 20 410-416.
220. H-G Chang, PF Smith, J Ackelsberg, et al. (2001) Intussusception, rotavirus diarrhea and rotavirus vaccine use among children in New York State. Pediatrics 108 54-60.
221. L Simonsen, DM Morens, A Elixhauser, et al. (2001) Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 358 1224-1229.
222. E Chang, KM Zangwill, H Lee and JI Ward (2002) Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J 21 97-102.
223. Z Lin, P Cohen, A Nissan, et al. (1998) Bacterial wall lipopolysaccharide as a cause of intussusception in mice. J Pediatr Gastroenterol Nutr 27 301-305.
224. A Nissan, J Zhang, Z Lin, et al. (1997) The contribution of inflammatory mediators and nitric oxide to lipopolysaccharide-induced intussusception in mice. J Surg Res 69 205-207.
225. M Ciarlet, MK Estes and ME Conner (2000) Simian rhesus rotavirus is a unique heterologous (non-lapine) rotavirus strain capable of productive replication and horizontal transmission in rabbits. J Gen Virol 81 1237-1249.
226. H Qiao, HF Clark, M DiVietro and M Riepenhoff-Talty (2004) A comparison of the effects of oral inoculation of RotaShieldTM and pentavalent reassortant vaccine (WC3-PV) on suckling CB17 scid mice. J Gen Virol 85 2245-2253.
227. CA Moser, D Dolfi, ML DiVietro, et al. (2001) Hypertrophy, hyperplasia and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotavirus. J Infect Dis 183 1108-1111.
228. RL Ward, AM Dinsmore, G Goldbery, et al. (1998) Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine. Pediatr Infect Dis J 17 386-390.
229. Prevention of rotavirus gastroenteritis among infants and children (2006) Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid Mortal Week Rep 55 12.
230. HF Clark, PA Offit, SA Plotkin and PM Heaton (2006) The new pentavalent rotavirus vaccine composed of bovine (strain WC3)-human rotavirus reassortants. PIDJ 25 577-583.
231. HF Clark, CJ Burke, DB Volken, et al. (2003) Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. PIDJ 22 914-920.
232. HF Clark, FE Borian, K Modesto and SA Plotkin (1990) Serotype l reassortant of bovine rotavirus WC3, strain Wl79–9, induces a polytypic antibody response in infants. Vaccine 8 327-332.
233. J Treanor, HF Clark, M Pichichero, et al. (1995) Evaluation of the protective efficacy of a serotype l human-bovine rotavirus reassortant vaccine in infants. Pediatr Infect Dis J 14 301-307.
234. HF Clark, PA Offit, RW Ellis, et al. (1996) WC3 reassortant vaccines in children: brief review. Arch Virol Suppl 12 187-198.
235. HF Clark, PA Offit, RW Ellis, et al. (1996) The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis 174(Suppl l), S73-S80.
236. HF Clark, FE Borian and SA Plotkin (1990) Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J Infect Dis 161 1099-1104.
237. Clark HF, Welsko D, Offit PA. Infant responses to bovine WC3 reassortants containing human rotavirus VP7, VP4, or VP7 and VP4 [abstr]. In: Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, October 11–14, 1992, p 343.
238. RL Ward, DR Knowlton, HB Greenberg, et al. (1990) Serum neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol 64 2687.
239. HF Clark, D Lawley, D Shrager, et al. (2004) infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79–9: different dose response patterns to virus surface proteins VP7 and VP4. PIDJ 23 206-211.
240. HF Clark, CJ White, PA Offit, et al. (1995) for the OHBRV Study Group Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine. Pediatr Res 37 172A.
241. HF Clark, PA Offit, RL Ward, et al. (2002) Safety, immunogenicity and efficacy of a quadrivalent reassortant rotavirus vaccine (QRV). Pediatr Res 51 282A.
242. HF Clark, DI Bernstein, PH Dennehey, et al. (2004) Safety, efficacy and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 144 184-190.
243. RL Ward, DI Bernstein, VE Smith, et al. (2004) Rotavirus immunoglobulin A responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine. JID 189 2290-2293.
244. Clark HF, Burke CJ, Volkin DB, et al. Safety and immunogenicity in healthy infants of G1 and G2 human reassortant rotavirus (HRV) vaccine in new stabilizer/buffer (S/B) liquid formulation [abstr]. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 27–30, 2002.
245. T Vesikari, HF Clark, PA Offit, et al. (2006) Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine 24 4821-4829.
246. HF Clark, CJ Burke, DB Volkin, et al. (2003) Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. Pediatr Infect Dis J 22 914-920.
247. T Vesikari, DO Matson, P Dennehy, et al. (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 23-33.
248. Makhene M, Midthun K, Karron R, et al. Safety and immunogenicity of human-UK bovine rotavirus reassortants in adults and pediatric subjects [abstr SV39]. In Program and Abstracts of the Fifth Rotavirus Vaccine Workshop, Atlanta, GA, October 16–17, 1995.
249. Centers for Disease Control and Prevention (2006) Prevention of Rotavirus Gastroenteritis Among Infants and Children Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55(No. RR-12), 1-13.
250. ML Clements-Mann, R Dudas, Y Hoshino, et al. (2001) Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine 19 4676-4684.
251. ML Clements-Mann, MK Makhene, J Mrukowicz, et al. (1999) Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3, 4 in adults, children and infants. Vaccine 17 2715-2725.
252. T Vesikari, AV Karvonen, J Majuri, et al. (2006) Safety, efficacy and immunogenicity o 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. JID 194 370-376.
253. Proceedings of the Seventh International Rotavirus Symposium, Lisbon Washington, D.C.: Albert B. Sabin Institute 12-13.
254. BK Das, JR Gentsch, Y Hoshino, et al. (1993) Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E. Virology 197 99-107.
255. SJ Dunn, HB Greenberg, RL Ward, et al. (1993) Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol 31 165-169.
256. MK Bhan, JF Lew, S Sazawal, et al. (1993) Protection conferred by neonatal rotavirus infection against subsequent diarrhea. J Infect Dis 168 282-287.
257. RR Vethanayagam, MA Babu, KS Nagalaxmi, et al. (2004) Possible role of neonatal infection with asymtomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988–1999. JID 189 2282-2289.
258. Bhandari N, Sharma P, Glass RI, et al. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: Results of a randomized controlled trial. Vaccine (in press).
259. Y Hoshino, RG Wyatt, J Flores, et al. (1985) Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections. J Clin Microbiol 21 425-430.
260. J Flores, I Perez-Schael, M Blanco, et al. (1990) Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine. Lancet 2 330-334.
261. T Vesikari, T Ruuska, H-P Koivu, et al. (1991) Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr Infect Dis J 10 912-917.
262. K Midthun, NA Halsey, M Jett-Goheen, et al. (1991) Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children and infants. J Infect Dis 164 792-796.
263. GL Barnes, J Lund, et al. (2002) Vaccine 20 2950-2956.
264. Barnes G, Bishop R, Lund J, et al. Phase 1 trial of a neonatal strain (RV3) rotavirus vaccine candidate [abstr SV33]. In Program and Abstracts of the Fifth Rotavirus Vaccine Workshop, Atlanta, GA, October 16–17, 1995.
265. DI Bernstein, DE Smith, JR Sherwood, et al. (1998) Safety and immunogenicity of live, attenuated human rotavirus vaccine 89–12. Vaccine 16 381-387.
266. DI Bernstein, DA Sack, E Rothstein, et al. (1999) Efficacy of live, attenuated human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial. Lancet 354 287-290.
267. Vesikari T, Karvonen A, Espo M, et al. Reactogenicity and immunogenicity of a human rotavirus vaccine (HRV), given as primary vaccination to healthy infants aged 6–12 weeks. Presented at the Conference on Vaccines for Enteric Diseases VED 2001, Tampere, Finland, September 12–14, 2001.
268. B De Vos, T Vesikari, AC Linhares, et al. (2004) A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J 23(10 Suppl), S179-S182.
269. KB Phua, SH Quak, BW Lee, et al. (2005) Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 192(Suppl 1), S6–S16.
270. PH Dennehy, RC Brady, SA Halperin, et al. (2005) Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 24(6), 481–488.
271. B de Vos (7–9 Jul 2004) Proceedings of the Sixth International Rotavirus Symposium Mexico City: Albert B. Sabin Vaccine Institute
272. T Vesikari, A Karvonen, L Puustinen, et al. (2004) Efficacy of RIX4414 live attenuated human rotavirus vaccine in finnish infants. Pediatr Infect Dis J 23(10 Suppl), 937-943.
273. B Salinas, I Perez Schael, AC Linhares, et al. (2005) Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in latin American infants. Pediatr Infect Dis J 24(9), 807–816.
274. GM Ruiz-Palacios, I Perez-Schael, FR Veláquez, et al. (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New Eng J Med 354(1), 11–21.
275. T Vesikari, A Karvonen, L Puustinen, et al. (2004) Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. PIDJ 23 937-943.
276. B Salinas, IP Schael, AC Linhares, et al. (2005) Evaluation of safety immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. PIDJ 24 807-816.
277. Vesikari T, Karvoven A, Prymula R, et al. RIX4414 (Rotarix™) is highly effective against severe RVGE caused by specific rotavirus types during the first two years of life. Abstract 668. 45 th Annual meeting of IDSA, Oct. 4–7, 2007, San Diego, CA.
278. T Vesikari, A Karvonen, T Korhonen, et al. (2004) Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 22 2836-2842.
279. KB Phua, SC Emmanuel, P Goh, et al. (2006) A Rotavirus Vaccine for Infants: The Asian Experience. Ann Acad Med 35 38-44.
280. European Medicines Agency. Online Available at:www.emea.europa.e Rotarix document, downloaded October 23, 2006
281. MMWR, March 16, 2007, Vol 56, no. 10:218–222.